Global Medical Devices in Cardiology Market Size, Share, Growth & Trends Analysis Report by Application (Coronary Artery Disease (Cad), Valvular Heart Disease (Vhd), Arrhythmias, Heart Failure, Congenital Heart Disease, Other Cardiovascular Applications) by End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare Settings, Other End Users) and Regional Outlook, Growth Potential & Forecast, 2024 – 2031

Loading...

Summary of Report:

The global medical devices in the cardiology market is substantial and continues to grow. Factors such as an aging population, increasing prevalence of cardiovascular diseases, and technological advancements contribute to the market’s expansion. Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality globally.

Price

$2,999.00
$3,999.00
$8,999.00

Do You have any Budget constraints?
Simply Ask our Sales Team About it.

Loading...

Description

The global medical devices in cardiology market is substantial and continues to grow. Factors such as an aging population, increasing prevalence of cardiovascular diseases, and technological advancements contribute to the market’s expansion. Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality globally. The rising incidence of conditions such as coronary artery disease, heart failure, and arrhythmias fuels the demand for advanced cardiology devices.

Continuous advancements in medical technology play a crucial role in the cardiology market. Innovations include the development of minimally invasive procedures, wearable devices for remote monitoring, and artificial intelligence applications in diagnostic imaging.

The market’s dynamics can vary by region due to differences in healthcare infrastructure, regulatory environments, and disease prevalence. Developed regions such as North America and Europe often lead in terms of technological adoption, while emerging economies in Asia-Pacific show significant growth potential.

Global Medical Devices in Cardiology Market: Covid-19 Impact

Many elective cardiac procedures, such as elective surgeries and non-urgent diagnostic tests, were postponed or canceled to prioritize resources for COVID-19 patients. This led to a temporary decline in certain cardiology-related medical device procedures.

Patients with chronic conditions, including cardiovascular diseases, faced challenges in accessing routine healthcare services due to lockdowns, fear of exposure, and overwhelmed healthcare systems. This had implications for the monitoring and management of cardiovascular health. The pandemic accelerated the adoption of telemedicine and remote patient monitoring, including for cardiac patients. Wearable devices and remote monitoring solutions gained prominence for managing chronic conditions and ensuring continuity of care.

Disruptions in the global supply chain affected the availability of medical devices, including those used in cardiology. The pandemic highlighted vulnerabilities in the supply chain and prompted discussions on building more resilient healthcare supply networks.

Global Medical Devices in Cardiology Market: Growth Drivers

  • Rising Incidence of Cardiovascular Diseases:

The global prevalence of cardiovascular diseases (CVDs), including heart attacks and strokes, continues to rise. As these conditions become more prevalent, the demand for advanced cardiology devices for diagnosis, treatment, and monitoring increases.

  • Aging Population:

The aging demographic is more prone to cardiovascular diseases. As the global population ages, there is a growing need for medical devices that can address the specific challenges associated with cardiovascular health in older individuals.

  • Technological Advancements:

Ongoing technological innovations play a crucial role in the growth of the cardiology devices market. Advancements such as minimally invasive procedures, robotics, artificial intelligence, and remote monitoring contribute to improved patient outcomes and drive market growth.

Global Medical Devices in Cardiology Market: Restraining factors

  • High Costs of Advanced Devices:

Many advanced cardiology devices, such as implantable cardioverter-defibrillators (ICDs) or advanced imaging systems, can be expensive. The high upfront costs of these devices can limit accessibility, particularly in healthcare systems with budget constraints.

  • Regulatory Challenges:

Stringent regulatory requirements and lengthy approval processes can slow down the introduction of new cardiology devices to the market. Compliance with regulations such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) can be resource-intensive and time-consuming.

  • Data Security and Privacy Concerns:

The increased use of digital health solutions, including remote monitoring and telemedicine, raises concerns about the security and privacy of patient data. Ensuring compliance with data protection regulations and addressing cybersecurity threats are ongoing challenges.

Global Medical Devices in Cardiology Market: Opportunity Factors

  • Technological Innovations:

Ongoing advancements in medical technology, including artificial intelligence, robotics, and miniaturized devices, present opportunities for the development of more efficient and effective cardiology devices. Innovations can lead to improved diagnostic accuracy and better patient outcomes.

  • Digital Health Integration:

Integration with digital health solutions, such as telemedicine platforms and mobile health applications, provides opportunities for remote patient monitoring, data analytics, and enhanced patient engagement. This shift toward digital health contributes to more accessible and patient-centric care.

  • Personalized Medicine:

The growing trend toward personalized medicine offers opportunities for the development of tailored treatment plans and devices based on individual patient characteristics. Advances in genomics and biomarkers contribute to the customization of therapies for better outcomes.

Global Medical Devices in Cardiology Market: Challenges

  • Regulatory Compliance:

Stringent regulatory requirements and complex approval processes can be a significant challenge for companies developing and introducing new cardiology devices. Navigating regulatory frameworks, such as those set by the FDA or EMA, requires significant resources and time.

  • Data Security and Privacy Concerns:

The increasing reliance on digital health solutions, remote monitoring, and telemedicine raises concerns about the security and privacy of patient data. Ensuring compliance with data protection regulations and implementing robust cybersecurity measures is an ongoing challenge.

  • High Development Costs:

The research, development, and clinical testing of advanced cardiology devices can be costly. Companies face the challenge of securing sufficient investment to fund these processes, especially for innovative technologies that may face higher development costs.

Global Medical Devices in Cardiology Market: Segmentation

By Application, the market is segmented by Coronary Artery Disease (CAD), Valvular Heart Disease (VHD), Arrhythmias, Heart Failure, Congenital Heart Disease, and Other Cardiovascular Applications. Devices for CAD focus on diagnostics, interventions, and monitoring related to the obstruction or narrowing of coronary arteries. This includes angioplasty catheters, stents, and diagnostic imaging equipment.

By End User the market is segmented by Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare Settings, and Other End Users. Devices for congenital heart disease address structural abnormalities present at birth. This segment includes devices for pediatric cardiology, such as septal occluders, shunts, and pediatric-sized implants.

Global Medical Devices in Cardiology Market: Regional Insights

  • United States: The U.S. is a major market for cardiology devices, driven by advanced healthcare infrastructure, a high prevalence of cardiovascular diseases, and significant investments in research and development. The regulatory environment, including FDA oversight, influences product approvals and market access.
  • European Union: European countries, with established healthcare systems, are key players in the cardiology devices market. The presence of regulatory bodies like the EMA and diverse healthcare policies across EU member states can impact market dynamics. Countries like Germany, the UK, and France are major contributors.
  • China: As a rapidly growing market, China has seen increased demand for cardiology devices due to lifestyle changes and a rising aging population. The regulatory landscape is evolving, and companies are adapting to market conditions.
  • India: With a growing middle class and increasing awareness of cardiovascular health, India presents opportunities. However, challenges include healthcare infrastructure disparities and regulatory complexities.
  • Brazil: Brazil is a significant market in Latin America, but economic factors and healthcare infrastructure disparities pose challenges. Regulatory frameworks may vary across countries in the region.
  • United Arab Emirates (UAE): The UAE has been investing in healthcare infrastructure and is a hub for medical tourism. Other countries in the region may face challenges related to economic constraints and varying levels of healthcare development.

Global Medical Devices in Cardiology Market: Key market players

  • Medtronic
  • Abbott Laboratories
  • Boston Scientific
  • Edwards Lifesciences
  • St. Jude Medical
  • Biotronik
  • Getinge
  • Terumo
  • W. L. Gore & Associates
  • Lepu Medical Technology

Table of Content

TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY DIAGNOSTIC AND MONITORING DEVICES
6.1. Overview
6.2. Electrocardiogram (ECG)
6.3. Remote Cardiac Monitoring
6.4. Other Diagnostic and Monitoring Devices
7. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY THERAPEUTIC AND SURGICAL DEVICES
7.1. Overview
7.2. Cardiac Assist Devices
7.3. Cardiac Rhythm Management Devices
7.4. Catheters
7.5. Grafts
7.6. Heart Valves
7.7. Stents
7.8. Other Therapeutic and Surgical Devices
8. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY REGION
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. South Korea
8.4.5. Australia
8.4.6. Rest of Asia-Pacific
8.5. Rest of the World
8.5.1. Middle East
8.5.2. Africa
8.5.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Medical Devices In Cardiology Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Medical Devices In Cardiology Market,
9.7. Key developments and Growth Strategies
9.7.1. New DIAGNOSTIC AND MONITORING DEVICES Launch/Therapeutic and Surgical Devices Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2022
9.8.2. Major Players R&D Expenditure. 2022
10. COMPANY PROFILES
10.1. Boston Scientific Corporation
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Diagnostic and Monitoring Devices Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Abbott
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Diagnostic and Monitoring Devices Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Medtronic
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Diagnostic and Monitoring Devices Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Edwards Lifesciences Corporation
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Diagnostic and Monitoring Devices Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Cardinal Health
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Diagnostic and Monitoring Devices Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies

Tables and Figures

List of Tables

Table 1. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET INDUSTRY SNAPSHOT, 2022-2031
Table 2. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET SHARE, BY PRODUCT -2019-2031 (USD BILLION)
Table 3. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR CARDIAC MONITORING DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 4. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR NEUROMONITORING DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 5. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR RESPIRATORY MONITORING DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 6. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR MULTI-PARAMETER MONITORING DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 7. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR HEMODYNAMIC MONITORING DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 8. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR FETAL AND NEONATAL MONITORING DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 9. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR TEMPERATURE MONITORING DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 10. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR WEIGHT MONITORING DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 11. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR DIAGNOSTIC DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 12. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR SURGICAL ENT DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 13. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR ENDOSCOPES, BY REGION-2019-2031 (USD BILLION)
Table 14. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR IMAGING DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 15. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR DIAGNOSTIC MOLECULAR DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 16. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR DRUG DELIVERY DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 17. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR SURGICAL DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 18. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR BIO IMPLANTS AND STIMULATION DEVICES, BY REGION-2019-2031 (USD BILLION)
Table 19. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR TREATMENT EQUIPMENT, BY REGION-2019-2031 (USD BILLION)
Table 20. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR INFUSION PUMPS, BY REGION-2019-2031 (USD BILLION)
Table 21. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR MEDICAL LASERS AND LASIK SURGICAL MACHINES, BY REGION-2019-2031 (USD BILLION)
Table 22. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR ELECTRONIC MEDICAL DEVICE, BY REGION-2019-2031 (USD BILLION)
Table 23. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR OTHERS, BY REGION-2019-2031 (USD BILLION)
Table 24. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET SHARE, BY THERAPEUTIC APPLICATION SIZE-2019-2031 (USD BILLION)
Table 25. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR GASTROINTESTINAL SURGERY, BY REGION-2019-2031 (USD BILLION)
Table 26. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR GENERAL SURGERY, BY REGION-2019-2031 (USD BILLION)
Table 27. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR DIAGNOSTIC IMAGING, BY REGION-2019-2031 (USD BILLION)
Table 28. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR RESPIRATORY, BY REGION-2019-2031 (USD BILLION)
Table 29. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR ORTHOPEDICS, BY REGION-2019-2031 (USD BILLION)
Table 30. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR CARDIOVASCULAR, BY REGION-2019-2031 (USD BILLION)
Table 31. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR DENTAL, BY REGION-2019-2031 (USD BILLION)
Table 32. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR NEUROLOGY, BY REGION-2019-2031 (USD BILLION)
Table 33. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR OPHTHALMOLOGY, BY REGION-2019-2031 (USD BILLION)
Table 34. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR EAR-NOSE-THROAT (ENT), BY REGION-2019-2031 (USD BILLION)
Table 35. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR NEPHROLOGY AND UROLOGY, BY REGION-2019-2031 (USD BILLION)
Table 36. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR OTHERS, BY REGION-2019-2031 (USD BILLION)
Table 37. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET SHARE, BY END USER-2019-2031 (USD BILLION)
Table 38. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR HOSPITALS & CLINICS, BY REGION-2019-2031 (USD BILLION)
Table 39. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR DIAGNOSTIC CENTERS, BY REGION-2019-2031 (USD BILLION)
Table 40. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR RESEARCH LABORATORY, BY REGION-2019-2031 (USD BILLION)
Table 41. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION-2019-2031 (USD BILLION)
Table 42. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET FOR OTHERS, BY REGION-2019-2031 (USD BILLION)
Table 43. NORTH AMERICA MEDICAL DEVICES MARKET BY COUNTRY, USD BILLION 2019-2031
Table 44. MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 45. MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 46. MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 47. U.S. MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 48. U.S. MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 49. U.S. MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 50. CANADA MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 51. CANADA MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 52. CANADA MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 53. EUROPE MEDICAL DEVICES MARKET BY COUNTRY, USD BILLION 2019-2031
Table 54. MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 55. MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 56. MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 57. GERMANY MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 58. GERMANY MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 59. GERMANY MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 60. ASIA PACIFIC MEDICAL DEVICES MARKET BY COUNTRY, USD BILLION 2019-2031
Table 61. MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 62. MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 63. MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 64. CHINA MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 65. CHINA MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 66. CHINA MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 67. LATIN AMERICA MEDICAL DEVICES MARKET BY COUNTRY, USD BILLION 2019-2031
Table 68. MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 69. MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 70. MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 71. BRAZIL MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 72. BRAZIL MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 73. BRAZIL MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 74. MEA MEDICAL DEVICES MARKET BY COUNTRY, USD BILLION 2019-2031
Table 75. MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 76. MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 77. MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 78. SOUTH AFRICA MEDICAL DEVICES MARKET SHARE, BY PRODUCT-2019-2031 (USD BILLION)
Table 79. SOUTH AFRICA MEDICAL DEVICES MARKET SHARE, BY THERAPEUTIC APPLICATION -2019-2031 (USD BILLION)
Table 80. SOUTH AFRICA MEDICAL DEVICES MARKET SHARE, BY END USER- 2019-2031 (USD BILLION)
Table 81. KEY EXPANSIONS (2019-2022)
Table 82. KEY MERGERS AND ACQUISITION (2019-2022)
Table 83. OTHER KEY DEVELOPMENTS (2019-2022)

List of Figures

Figure 1. REGIONAL ANALYSIS (2022 & 2031)
Figure 2. CXO PERSPECTIVE
Figure 3. UNTAPPED REVENUE OPPORTUNITIES
Figure 4. GROWTH PIPELINE FUNNEL
Figure 5. TOP INVESTMENT POCKETS
Figure 6. INSIGHTS FROM EXPERT INTERVIEWS
Figure 7. INSIGHTS FROM EXPERT INTERVIEWS
Figure 8. MARKET SCENARIOS: PESSIMISTIC VS. OPTIMISTIC VS. REALISTIC
Figure 9. ABSOLUTE MARKET OPPORTUNITY (2023-2030)
Figure 10. STRATEGIC FINDINGS OF THE MARKET
Figure 11. ANALYST VIEW
Figure 12. BUSINESS MODEL CANVA
Figure 13. RESEARCH PROCESS
Figure 14. ANALYSIS FRAMEWORK
Figure 15. IMPACT OF KEY REGULATION ON THE MARKET
Figure 16. SWOT ANALYSIS
Figure 17. SUPPLY CHAIN ANALYSIS
Figure 18. FUTURE PERSPECTIVE
Figure 19. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET SHARE, BY PRODUCT -2024 & 2031 (USD BILLION)
Figure 20. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY CARDIAC MONITORING DEVICES-2019-2031 (USD BILLION)
Figure 21. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY NEUROMONITORING DEVICES-2019-2031 (USD BILLION)
Figure 22. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY RESPIRATORY MONITORING DEVICES-2019-2031 (USD BILLION)
Figure 23. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY MULTI-PARAMETER MONITORING DEVICES-2019-2031 (USD BILLION)
Figure 24. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY HEMODYNAMIC MONITORING DEVICES-2019-2031 (USD BILLION)
Figure 25. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY FETAL AND NEONATAL MONITORING DEVICES-2019-2031 (USD BILLION)
Figure 26. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY TEMPERATURE MONITORING DEVICES-2019-2031 (USD BILLION)
Figure 27. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY WEIGHT MONITORING DEVICES-2019-2031 (USD BILLION)
Figure 28. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY DIAGNOSTIC DEVICES-2019-2031 (USD BILLION)
Figure 29. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY SURGICAL ENT DEVICES-2019-2031 (USD BILLION)
Figure 30. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY ENDOSCOPES-2019-2031 (USD BILLION)
Figure 31. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY IMAGING DEVICES-2019-2031 (USD BILLION)
Figure 32. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY DIAGNOSTIC MOLECULAR DEVICES-2019-2031 (USD BILLION)
Figure 33. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY DRUG DELIVERY DEVICES-2019-2031 (USD BILLION)
Figure 34. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY SURGICAL DEVICES-2019-2031 (USD BILLION)
Figure 35. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY BIO IMPLANTS AND STIMULATION DEVICES-2019-2031 (USD BILLION)
Figure 36. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY TREATMENT EQUIPMENT-2019-2031 (USD BILLION)
Figure 37. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY INFUSION PUMPS-2019-2031 (USD BILLION)
Figure 38. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY MEDICAL LASERS AND LASIK SURGICAL MACHINES-2019-2031 (USD BILLION)
Figure 39. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY ELECTRONIC MEDICAL DEVICE-2019-2031 (USD BILLION)
Figure 40. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY OTHERS-2019-2031 (USD BILLION)
Figure 41. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET SHARE, BY THERAPEUTIC APPLICATION -2024 & 2031 (USD BILLION)
Figure 42. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY GASTROINTESTINAL SURGERY-2019-2031 (USD BILLION)
Figure 43. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY GENERAL SURGERY-2019-2031 (USD BILLION)
Figure 44. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY DIAGNOSTIC IMAGING-2019-2031 (USD BILLION)
Figure 45. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY RESPIRATORY-2019-2031 (USD BILLION)
Figure 46. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY ORTHOPEDICS-2019-2031 (USD BILLION)
Figure 47. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY CARDIOVASCULAR-2019-2031 (USD BILLION)
Figure 48. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY DENTAL-2019-2031 (USD BILLION)
Figure 49. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY NEUROLOGY-2019-2031 (USD BILLION)
Figure 50. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY OPHTHALMOLOGY-2019-2031 (USD BILLION)
Figure 51. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY EAR-NOSE-THROAT (ENT)-2019-2031 (USD BILLION)
Figure 52. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY NEPHROLOGY AND UROLOGY-2019-2031 (USD BILLION)
Figure 53. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY OTHERS-2019-2031 (USD BILLION)
Figure 54. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET SHARE, BY END USER -2024 & 2031 (USD BILLION)
Figure 55. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY HOSPITALS & CLINICS-2019-2031 (USD BILLION)
Figure 56. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY DIAGNOSTIC CENTERS-2019-2031 (USD BILLION)
Figure 57. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY RESEARCH LABORATORY-2019-2031 (USD BILLION)
Figure 58. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY PHARMACEUTICAL COMPANIES-2019-2031 (USD BILLION)
Figure 59. GLOBAL MEDICAL DEVICES IN CARDIOLOGY MARKET, BY OTHERS-2019-2031 (USD BILLION)
Figure 60. MARKET OPPORTUNITY FOR COMPANY
Figure 61. MARKET POSITIONING ANALYSIS
Figure 62. MARKET SHARE, BY COMPANY
Figure 63. MARKET PLAYER POSITIONING, 2022
Figure 64. COMPANY EVALUATION MATRIX
Figure 65. PRODUCT MAPPING OF TOP 10 PLAYERS
Figure 66. COMPETITIVE HEATMAP OF KEY PLAYERS

Frequently Asked Questions

  • What are the key factors driving the Medical Devices in Cardiology Market?

    The rising incidence of chronic cardiovascular illnesses worldwide is a major factor driving the global market for cardiovascular devices. Cardiovascular illnesses are the world's biggest cause of mortality, according to the World Health Organization.
  • Which region will contribute ably towards the Medical Devices in Cardiology Market?

    The North America region has captured largest of the revenue share in 2023.
  • What are the key players in Medical Devices in Cardiology Market?

    B Braun Melsungen AG, Medtronic, Abbott, Johnson & Johnson Services, Inc. and others are the key players in Medical Devices in Cardiology Market